Science, not politics, should guide decisions about research | Clinical trial of gene therapy expands for dogs with joint pain | Researchers study monkeys of Cayo Santiago to learn about post-traumatic stress
May 22, 2019
FBR Smartbrief
Top Story
Science, not politics, should guide decisions about research
If activists succeed in pushing Congress to defund studies involving dogs and cats, they will end up hurting the very animals they seek to protect. "Bottom line is, science should be driving the decision over which models are most appropriate for research -- not pressure from activist groups, animal rights extremists or legislators," says Rocco Praglowski, the government affairs director for the National Association for Biomedical Research.
Laboratory Equipment (5/21) 
LinkedIn Twitter Facebook Email
Clinical trial of gene therapy expands for dogs with joint pain
Clinical trial of gene therapy expands for dogs with joint pain
Veterinarian Rob Landry is seeking more dogs in Colorado to participate in a clinical study of interleukin-10 gene therapy for dogs with degenerative joint arthritis or dysplasia whose pain has not been eased by medication. Human trials of the therapy are also underway in California and Australia, and if successful, it could reduce demand for opioid pain drugs and joint replacements.
KCNC-TV (Denver) (5/21) 
LinkedIn Twitter Facebook Email
Research Breakthroughs
Researchers study monkeys of Cayo Santiago to learn about post-traumatic stress
Researchers have studied monkeys at Cayo Santiago for decades, and in the aftermath of Hurricane Maria, researchers may be able to learn how survivors of a disaster cope and identify individual traits that might put some at risk for psychological problems. The death rate among the monkeys spiked in the months after the storm, as did the human death rate in Puerto Rico, and researchers have noted behavioral and social changes, too.
The New York Times (tiered subscription model) (5/14) 
LinkedIn Twitter Facebook Email
Alzheimer's drug shows promise in early-stage human trials
An experimental drug called PRI-002, which removes toxic beta-amyloid molecules, was safe and tolerated in an early-stage trial involving healthy people, making it eligible for a midstage trial assessing its efficacy in patients with Alzheimer's disease. A prior study in the journal Molecular Neurobiology found that older mouse models with Alzheimer's disease had significantly improved memory and cognition after receiving the treatment.
Medical News Today (5/15) 
LinkedIn Twitter Facebook Email
Molecules from lampreys' immune systems carry cancer drugs to mouse brains
Molecules from lampreys' immune systems carry cancer drugs to mouse brains
(Miguel Riopa/AFP/Getty Images)
Defensive molecules from lampreys were used to deliver the cancer drug doxorubicin into the brains of mice with glioblastoma, significantly extending life span compared with a control group, researchers reported in Science Advances. The molecules circulated through the body but did not accumulate in other organs or in healthy brain tissue, and the researchers believe they could also be used to treat brain trauma or stroke.
New Atlas (5/17),  Medical News Today (5/19) 
LinkedIn Twitter Facebook Email
B cells tweaked with CRISPR create virus-fighting antibodies in mice
B cells in mice were modified with CRISPR-Cas9 to make them express antibodies against respiratory syncytial virus, researchers reported in Science Immunology. Scientists hope their research can lead to vaccines for RSV as well as influenza, Epstein-Barr virus and HIV, but "[b]efore this goes into people, we have to be absolutely certain that it's safe," said study leader Justin Taylor.
The Scientist online (5/17) 
LinkedIn Twitter Facebook Email
Other News
Animal Health
Zoo teaches gorillas to undergo heart screening
Veterinarians and handlers at Cincinnati Zoo have taught the zoo's gorillas to allow periodic heart screenings as part of the international Great Ape Heart Project. Like humans, great apes are prone to heart disease, and one of the zoo's female gorillas is now on heart medication to treat problems identified through screening.
WLWT-TV (Cincinnati) (5/14) 
LinkedIn Twitter Facebook Email
Policy News
House bill would require agencies to have post-research plan for lab animals
A House bill would require all federal agencies to establish a policy for retiring lab animals protected under the Animal Welfare Act after research is completed.
CNN (5/20) 
LinkedIn Twitter Facebook Email
FBR News
New FBR resource: Animal Research Perceptions vs. Reality
Animal rights groups mislead the public about animal research, but FBR is fighting back with facts. In this resource, highly respected neuro-oncologist and FBR Board Vice-Chair Dr. Henry S. Friedman refutes myths surrounding animal research with scientific evidence and sets the record straight on the reality and benefits of animal research. Check it out.
LinkedIn Twitter Facebook Email
Donate to FBR
For 35 years, FBR has advanced biomedical research for the sake of both human and animal health. We can't do our job without your support. Please give what you can. Together we will continue to make a difference.
LinkedIn Twitter Facebook Email
All creative people want to do the unexpected.
Hedy Lamarr,
actress and inventor of spread spectrum communication technology

May is National Inventors Month

LinkedIn Twitter Facebook Email
Learn more about FBR:
About FBR | Donate
About FBR
The Foundation for Biomedical Research (FBR) is the nation’s oldest and largest non-profit dedicated to improving human and animal health by promoting public understanding and support for biomedical research. Our mission is to educate people about the essential role animal research plays in the quest for medical advancements, treatments and cures for both people and animals.
Sign Up
SmartBrief offers 200+ newsletters
Subscriber Tools:
Contact Us:
Editor  -  Melissa Turner
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2019 SmartBrief, Inc.®
Privacy Policy (updated May 25, 2018) |  Legal Information